Literature DB >> 15292769

Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community population.

Joseph Hung1, Brendan M McQuillan, Caroline M L Chapman, Peter L Thompson, John P Beilby.   

Abstract

BACKGROUND: The monocyte receptor CD14 is an important mediator of the inflammatory response to bacterial endotoxin. Recently, a functional polymorphism in the promoter of the CD14 gene (CD14-260C>T) was found to be associated with coronary heart disease. We examined if this polymorphism was associated with sub-clinical carotid atherosclerosis in a community population. DESIGN AND METHODS: A randomly selected community population (557 men and 553 women; aged 27-77 years) underwent conventional risk factor assessment and ultrasound evaluation of the common carotid intima-medial wall thickness (IMT) and carotid plaque formation. CD14-260C>T genotypes were examined by restriction fragment length polymorphism analysis. Chlamydia pneumoniae-specific immunoglobulin G (IgG) and immunoglobulin A (IgA) antibody titres were determined by micro-immunofluorescence.
RESULTS: The carrier frequency of the T allele and TT genotype was 0.48 and 0.22 respectively. Genotype frequencies met Hardy-Weinberg expectation. There was no significant association of -260C>T genotypes with traditional risk factors. On multivariate analysis, there was no independent association of genotypes with common carotid IMT in men and women or with prevalence of carotid plaque in women. Contrary to expectation, men who were TT homozygotes relative to CC wild-type had a lower adjusted risk of carotid plaque formation (odds ratio 0.34, 95% confidence interval 0.17-0.69; P=0.003). There was no evidence that smoking or C. pneumoniae infection modified the association of genotypes with carotid IMT or plaque formation.
CONCLUSION: The CD14-260C>T gene polymorphism was not associated with an increased risk of sub-clinical carotid atherosclerosis in a community population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292769     DOI: 10.1097/01.hjr.0000129741.07723.6c

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  5 in total

1.  Critical investigation of the CD14 promoter polymorphism: lack of a role for in vitro cytokine response and membrane CD14 expression.

Authors:  Sonja von Aulock; Jan Rupp; Katja Gueinzius; Matthias Maass; Corinna Hermann
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

Review 2.  Genetic determinants of carotid ultrasound traits.

Authors:  Rebecca L Pollex; Robert Hegele
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

3.  Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults.

Authors:  Alex P Reiner; Ethan M Lange; Nancy S Jenny; Paulo H M Chaves; Jaclyn Ellis; Jin Li; Jeremy Walston; Leslie A Lange; Mary Cushman; Russell P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

4.  Outcome of urogenital infection with Chlamydia muridarum in CD14 gene knockout mice.

Authors:  Muhammad T Imtiaz; Justin H Schripsema; Ira M Sigar; Kyle H Ramsey
Journal:  BMC Infect Dis       Date:  2006-09-22       Impact factor: 3.090

5.  Ischemic stroke risk, smoking, and the genetics of inflammation in a biracial population: the stroke prevention in young women study.

Authors:  John W Cole; David W Brown; Wayne H Giles; Oscar C Stine; Jeffrey R O'Connell; Braxton D Mitchell; John D Sorkin; Marcella A Wozniak; Barney J Stern; Mary J Sparks; Mark T Dobbins; Latasha T Shoffner; Nancy K Zappala; Laurie J Reinhart; Steven J Kittner
Journal:  Thromb J       Date:  2008-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.